Two Republican leaders in the House of Representatives have published a “framework” for reforming NIH—consolidating the agency’s 27 institutes and centers into 15—arguing that a fundamental rethinking of NIH’s structure would fix what they describe as a “system rife with stagnant leadership, as well as research duplication, gaps, and misconduct.”
NCI Director Kimryn Rathmell joined the NIH director and four other institute directors in a May 23 Senate subcommittee hearing to craft the Labor-HHS spending bill for fiscal year 2025.
Sen. Richard J. Durbin (D-IL) has asked Amgen to provide copies of the company’s communications with FDA related to the dosage of Lumakras (sotorasib), a KRAS inhibitor marketed under an accelerated approval for non-small cell lung cancer.
Credit: National Cancer Institute, National Institutes of HealthHalfway into fiscal year 2024, NCI officials are crunching numbers, trying to find ways to live with an appropriation that, for the first time since sequestration, reduces the institute’s spending power.
As NCI continues to hobble along on a flat budget provided by a succession of continuing resolutions, the prospects for robust funding for cancer research, rising paylines, and healthy cancer center support grants have dimmed for this fiscal year. “The extended delay in passing the FY2024 budget is disastrous for our cancer centers,” Jennifer W.... […]
The House Committee on Energy and Commerce has issued a subpoena to require NIH Director Monica Bertagnolli to provide information related to NIH’s handling of allegations of sexual harassment and workplace misconduct.
Monica M. Bertagnolli, the 16th NCI director, has been confirmed as the 17th director of NIH—six months after the White House first named her to lead the world’s largest public funder of biomedical research.
Monica Bertagnolli testifies during her Senate Health, Education, Labor and Pensions Committee confirmation hearing to be the next NIH Director, Oct. 18, 2023 Photo credit: Kevin Dietsch/Getty ImagesA Senate Committee Oct. 25 voted 15-6 to advance the confirmation of Monica Bertagnolli to the role of NIH director.
At a Senate hearing that considered her nomination to the post of NIH director, Monica Bertagnolli laid out an agenda that includes expanding access to clinical trials and making health care innovation affordable and accessible to the public.
A House oversight committee said it intends to exercise the power of subpoena to compel the NIH Office of the Director to turn over documents related to allegations of sexual harassment and workplace misconduct.
